Cardiac Troponin T
Following Repeated Administration of Pyridoxal Isonicotinoyl
Hydrazone in Rabbits
M. ADAMCOVÁ, J. MACHÁČKOVÁ, V. GERŠL, V.
PELOUCH1, T. ŠIMŮNEK2,
I. KLIMTOVÁ2, R. HRDINA2, P. POŇKA3
Charles University in Prague, Faculty of
Medicine in Hradec Králové, 2Faculty of Pharmacy in
Hradec Králové, 1Second Faculty of Medicine in Prague,
Czech Republic, 3McGill University, Montreal, Canada
Received April 6, 2001
Accepted April 5, 2002
Summary
Pyridoxal isonicotinoyl hydrazone (PIH) is a new tridentate Fe-chelating
agent that should be very promising in many pathological states
resulting from both an iron-overload and formation of free
radicals. The aim of our study was to investigate the effect of
PIH on the cardiovascular system focusing to the regulatory
protein - cardiac troponin T (cTnT). The study was carried out
in two groups of Chinchilla male rabbits: 1) PIH (50 mg/kg
dissolved in 10 % Cremophor i.p., once a week, 10
administrations, n=8) and 2) Cremophor (2 ml/kg i.p. in the same
schedule, n=7). Plasma concentrations of cTnT (as a marker of
myocardial damage) were measured using a commercial kit (Roche).
cTnT was within the physiological range (i.e. < 0.1 mg/l) during
the whole experiment in the Cremophor group. In the PIH group,
the cTnT levels were not significantly increased when compared
with the control group or with the initial values (except with
those before the 5th administration). Furthermore, we analyzed
the cytosolic and myofibrillar fraction of cTnT in the left
ventricular myocardium. Using SDS-PAGE and Western blot we
resolved three isoforms. The profiling of TnT did not differ
significantly between the PIH-treated group and the Cremophor-treated
group. Our data concerning cTnT support the opinion that the
possible cardiotoxicity of PIH is very low.
Key
words
Iron chelators · Cardiotoxicity
· Cardiac troponin T · Protein profile · Rabbits
Reprint
requests
MUDr. M. Adamcová, CSc., Department of Physiology, Faculty of
Medicine of Charles University, Šimkova 870, CZ-50001 Hradec
Králové. E-mail: adamcova@lfhk.cuni.cz
|